Skip to Main Content

Paper Details

Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.
Oncotarget
62
2016
Author NameAffiliation
Laura Z Rassenti
Thomas J Kippsuniversity of california san diego-Moores Cancer Center
Thomas J Kipps
  • 1 - 3

Datasets

Release 1.2